ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Percentage of in-patients Developing Adverse Drug Reaction
2
Indicator Name:Percentage of in-patients developing adverse drug reactionJANFEBMARAPRMAYJUNJULAUGSEPOCTNOVDEC
3
Numerator:Number of adverse drug reactions reportedX 100Numerator
4
DenominatorNumber of inpatients in a monthDenominator
5
RationaleMonitors the percentage of inpatients who develop adverse drug reactions during their hospital stay. Supports patient safety and regulatory complianceRate#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!#DIV/0!
6
Inclusion CriteriaAll adverse drug reactions (ADRs) reported in IPDTarget 0%0%0%0%0%0%0%0%0%0%0%0%0%
7
Exclusion CriteriaOutpatient ADRs,Patient’s pre-existing conditions misclassified as ADRs.
8
Indicator Owner: Clinical Pharmacist
9
Selection criteria:√High Risk □ High Volume □IPSG √ Problem Prone □High Cost
10
□ Contract Monitoring √ Regulatory Requirement
11
√ Others: Accreditation requirement
12
Type of Indicator:□ Structure □ Process √ Outcome □ Process & Outcome
13
Frequency:√Monthly Quarterly Bi-Annual Annual
14
Department/ Unit
15
Sample Size: All discharges and death
16
Data collection method / Source KPI facilitator will audit the medical record & every months and record in observations into the KPI data collection tool.
17
Data methodology:□ Retrospective √ Concurrent
18
Unit of MeasurementPercentage
19
Target:0%
20
Benchmark (If Applicable)
21
Data Analysis:
22
Common variations
23
24
Action plan:
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100